These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3748472)
1. Morphological changes in rat striatal boutons after chronic methamphetamine and haloperidol treatment. Ihara Y; Sato M; Otsuki S; Kaiya H; Namba M Neurosci Res; 1986 Jul; 3(5):403-10. PubMed ID: 3748472 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum. Kashihara K; Fukuda K; Sato M; Otsuki S Neurosci Res; 1987 Jun; 4(5):428-32. PubMed ID: 3670749 [TBL] [Abstract][Full Text] [Related]
3. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Killinger BA; Moszczynska A J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine. Yamada S; Kojima H; Yokoo H; Tsutsumi T; Takamuki K; Anraku S; Nishi S; Inanaga K Biol Psychiatry; 1988 Aug; 24(4):399-408. PubMed ID: 3408757 [TBL] [Abstract][Full Text] [Related]
5. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Kerns JM; Sierens DK; Kao LC; Klawans HL; Carvey PM Clin Neuropharmacol; 1992 Dec; 15(6):488-500. PubMed ID: 1335837 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Seeger TF; Thal L; Gardner EL Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029 [TBL] [Abstract][Full Text] [Related]
8. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine. Bjorklund NL; Sorg BA; Schenk JO Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643 [TBL] [Abstract][Full Text] [Related]
9. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats. Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388 [TBL] [Abstract][Full Text] [Related]
10. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Prosser ES; Pruthi R; Csernansky JG Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment. Roberts RC; Force M; Kung L Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine. Yamanaka Y; Takano R; Egashira T Jpn J Pharmacol; 1986 Jun; 41(2):147-54. PubMed ID: 3091891 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915 [TBL] [Abstract][Full Text] [Related]
15. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics. Kuczenski R; Schmidt D; Leith N Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038 [TBL] [Abstract][Full Text] [Related]
16. Effects of dopamine antagonists on methamphetamine-induced dopamine release in high and low alcohol preference rats. Nishiguchi M; Kinoshita H; Kasuda S; Takahashi M; Yamamura T; Matsui K; Ouchi H; Minami T; Hishida S; Nishio H Toxicol Mech Methods; 2010 Mar; 20(3):127-32. PubMed ID: 20163290 [TBL] [Abstract][Full Text] [Related]
17. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Kazahaya Y; Akimoto K; Otsuki S Biol Psychiatry; 1989 Apr; 25(7):903-12. PubMed ID: 2720005 [TBL] [Abstract][Full Text] [Related]
18. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding. Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118 [TBL] [Abstract][Full Text] [Related]
19. The effects of haloperidol on synaptic patterns in the rat striatum. Benes FM; Paskevich PA; Davidson J; Domesick VB Brain Res; 1985 Mar; 329(1-2):265-73. PubMed ID: 3978446 [TBL] [Abstract][Full Text] [Related]
20. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol. Umeda Y; Sumi T Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]